Growth hormone is not safe for children with renal transplants

A. L. Friedman

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Growth failure is an important problem in children with renal failure. Even after renal transplantation their growth rates may be lower than normal, and 'catch-up' growth does not occur. Therefore there is great interest in giving growth hormone (GH) after transplantation. Clinical observations and theoretic considerations call into question whether GH after transplantation is safe. Studies have shown a more rapid than normal decline in renal function after the initiation of GH therapy. This result could be explained by the effects of GH on the immune response. Growth hormone is known to modulate (usually upregulate) the immune response and could be a reason for the increased loss of renal function caused by rejection. It could also be explained by the long-term effects of GH on the injured kidney. Experimental data (generally not in the transplantation model) suggest that exogenous GH given after renal injury or reduced renal mass leads to a more rapid development of glomerular sclerosis and reduced renal function. GH should not be administered to children after renal transplantation until all safety questions have been answered in prospective clinical trials.

Original languageEnglish (US)
Pages (from-to)S25-S27
JournalJournal of Pediatrics
Issue number1 II SUPPL.
StatePublished - 1997

Bibliographical note

Copyright 2021 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Growth hormone is not safe for children with renal transplants'. Together they form a unique fingerprint.

Cite this